Vault-13

VERONA PHARMA PLC VRNA

SPONSORED ADS · ADR · CUSIP 925050106

1 institutional holders -243 vs Q3 2025
20,00020.0k shares reported held*
$359.0kreported value*
0 new 0 added 0 reduced 231 sold out net sold ≈ $1.3bn (-73.0m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $17.95.

Trends to Q4 2025

Institutional holders

Managers reporting a position, each quarter

0100200300Q3 22: 69Q4 22: 89Q1 23: 96Q2 23: 106Q3 23: 103Q4 23: 118Q1 24: 114Q2 24: 126Q3 24: 151Q4 24: 192Q1 25: 261Q2 25: 294Q3 25: 244Q4 25: 11Q3 22Q2 23Q1 24Q4 24Q4 25
Numbers
QuarterHolders
Q3 202269
Q4 202289
Q1 202396
Q2 2023106
Q3 2023103
Q4 2023118
Q1 2024114
Q2 2024126
Q3 2024151
Q4 2024192
Q1 2025261
Q2 2025294
Q3 2025244
Q4 20251

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
4000400Q1 24: 59 bought or addedQ1 24: 47 cut or sold outQ2 24: 69 bought or addedQ2 24: 46 cut or sold outQ2 24Q3 24: 83 bought or addedQ3 24: 67 cut or sold outQ4 24: 104 bought or addedQ4 24: 70 cut or sold outQ4 24Q1 25: 157 bought or addedQ1 25: 99 cut or sold outQ2 25: 148 bought or addedQ2 25: 140 cut or sold outQ2 25Q3 25: 132 bought or addedQ3 25: 216 cut or sold outQ4 25: 0 bought or addedQ4 25: 231 cut or sold outQ4 25
Numbers
QuarterBought or addedCut or sold out
Q1 20245947
Q2 20246946
Q3 20248367
Q4 202410470
Q1 202515799
Q2 2025148140
Q3 2025132216
Q4 20250231

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$100m$200m$300m$400mQ1 25 calls: $70.5mQ1 25 puts: $144.0mQ1 25P/C 2.04Q2 25 calls: $102.0mQ2 25 puts: $327.7mQ2 25P/C 3.21Q3 25 calls: $78.3mQ3 25 puts: $59.8mQ3 25P/C 0.76Q4 25 calls: $0Q4 25 puts: $0Q4 25P/C —
Numbers
QuarterCallsPutsP/C
Q1 2025$70.5m$144.0m2.04
Q2 2025$102.0m$327.7m3.21
Q3 2025$78.3m$59.8m0.76
Q4 2025$0$0—

Biggest buyers

None

Biggest sellers

Pentwater Capital Management LP Sold out -5,300,000-5.3m
HBK INVESTMENTS L P Sold out -4,263,576-4.3m
BlackRock, Inc. Sold out -3,826,710-3.8m
FIL Ltd Sold out -3,488,500-3.5m
Frazier Life Sciences Management, L.P. Sold out -3,383,950-3.4m
GLAZER CAPITAL, LLC Sold out -3,205,878-3.2m
JPMORGAN CHASE & CO Sold out -2,829,540-2.8m
NEA Management Company, LLC Sold out -2,252,994-2.3m
GOLDMAN SACHS GROUP INC Sold out -1,935,278-1.9m
Balyasny Asset Management L.P. Sold out -1,863,426-1.9m

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

No one currently above 5% in the filings since 19 Dec 2024.

Fell to 5% or below in the last year: PERCEPTIVE ADVISORS LLC (0.0%, 2025-11-14), JANUS HENDERSON GROUP PLC (1.2%, 2025-11-14), Pentwater Capital Management LP (0.0%, 2025-11-14)

Holders, Q4 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 DekaBank Deutsche Girozentrale 0.00% of their portfolio FRANKFURT, 2M 20,00020.0k $359.0k $359.0k 0.00% Unchanged